Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 2 Study of CRLX101 in Patients With Advanced Non-Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Cerulean Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01380769
First received: June 22, 2011
Last updated: July 9, 2014
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)